“Long-Term Safety and Efficacy of Belzutifan in Von Hippel–Lindau Syndrome: A VHL Coordinating Care Center Experience”. Journal of Kidney Cancer, vol. 12, no. 3, Sept. 2025, pp. 25-31, https://doi.org/10.15586/jkcvhl.v12i3.425.